What adverse reactions happened during this study?
The most common adverse reaction was an injection site reaction.
The tables below show the adverse reactions that happened in more than
1 participant during the study. There were other adverse reactions, but these
happened in fewer participants.
Most common adverse reactions related to MEDI5083
Part 1 Part 2
(out of 29 participants) (out of 9 participants)
Injection site reaction 86.2% (25) 100.0% (9)
Fatigue 13.8% (4) 11.1% (1)
Fever 10.3% (3) 11.1% (1)
Injection site pain 10.3% (3) 0.0% (0)
Injection site redness 6.9% (2) 0.0% (0)
Most common adverse reactions related to durvalumab
Only 18 of the 29 participants in Part 1 received any durvalumab. So, the results
below are for those 18 participants.
Part 1 Part 2
(out of 18 participants) (out of 9 participants)
Fatigue 11.1% (2) 22.2% (2)
Diarrhea 11.1% (2) 11.1% (1)
Low levels of thyroid hormones 11.1% (2) 0.0% (0)
Joint pain 11.1% (2) 0.0% (0)
Itchiness 11.1% (2) 0.0% (0)
10 | Clinical Study Results